MedPath

Respinor AS

🇳🇴Norway
Ownership
-
Employees
-
Market Cap
-
Website

Multicenter, Multinational, Follow-Up Clinical Trial of the Performance of RESPINOR DXT to Identify Patients at Increased Risk of Weaning Failure

Completed
Conditions
Respiratory Failure
Interventions
Device: RESPINOR DXT
First Posted Date
2022-10-14
Last Posted Date
2023-12-18
Lead Sponsor
Respinor AS
Target Recruit Count
145
Registration Number
NCT05580185
Locations
🇫🇷

Hopital Saint-Antoine, Paris, Cedex 12, France

🇫🇷

Centre Hospitalier Saint Joseph Saint Luc, Lyon, France

🇫🇷

CHU Angers, Angers, France

and more 5 locations

Multicenter, Multinational, Clinical Trial of the Performance of RESPINOR DXT to Identify Patients at Increased Risk of Weaning Failure

Completed
Conditions
Respiratory Failure
Interventions
Device: RESPINOR DXT
First Posted Date
2021-01-06
Last Posted Date
2023-12-19
Lead Sponsor
Respinor AS
Target Recruit Count
193
Registration Number
NCT04696406
Locations
🇫🇷

Centre Hospitalier Universitaire de Montpellier, Montpellier, Select One..., France

🇮🇹

Ospedale San Carlo Borromeo, Milan, Italy

🇫🇷

Hopital Saint-Antoine, Paris, Cedex 12, France

and more 6 locations

Improvement of Weaning From Mechanical Ventilation by Continuous Ultrasound Monitoring of Diaphragm Excursion

Completed
Conditions
Respiration, Artificial
First Posted Date
2019-07-05
Last Posted Date
2021-06-14
Lead Sponsor
Respinor AS
Target Recruit Count
39
Registration Number
NCT04008875
Locations
🇫🇷

Hôpital Universitaire Pitié Salpêtrière, Paris, France

🇫🇷

CHU Angers, Angers, France

🇫🇷

CH Saint Joseph Saint Luc, Lyon, France

Continuous Measurement of Diaphragm Excursion as a Predictor of Extubation Failure

Completed
Conditions
Respiration, Artificial
First Posted Date
2019-03-29
Last Posted Date
2021-06-14
Lead Sponsor
Respinor AS
Target Recruit Count
11
Registration Number
NCT03896048
Locations
🇳🇴

St Olav's Hospital, Trondheim, Norway

© Copyright 2025. All Rights Reserved by MedPath